Cannell & Spears LLC Reduces Position in Xylem Inc. $XYL

Cannell & Spears LLC cut its stake in Xylem Inc. (NYSE:XYL) by 38.2% during the first quarter, HoldingsChannel reports. The firm owned 117,415 shares of the industrial products company’s stock after selling 72,565 shares during the period. Cannell & Spears LLC’s holdings in Xylem were worth $14,025,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Callahan Advisors LLC purchased a new position in shares of Xylem in the 4th quarter valued at approximately $1,721,000. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Xylem by 2,309.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after buying an additional 413,904 shares during the last quarter. Abacus Wealth Partners LLC acquired a new stake in shares of Xylem during the 4th quarter worth approximately $1,663,000. Boston Common Asset Management LLC increased its holdings in Xylem by 15.3% in the fourth quarter. Boston Common Asset Management LLC now owns 143,740 shares of the industrial products company’s stock valued at $19,575,000 after buying an additional 19,073 shares in the last quarter. Finally, Norges Bank purchased a new position in shares of Xylem in the 4th quarter valued at about $361,012,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Xylem

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at approximately $423,443.30. This represents a 54.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Jerome A. Peribere acquired 1,210 shares of the stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.32% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have weighed in on XYL. CLSA upgraded shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and upped their target price for the company from $130.00 to $140.00 in a report on Thursday, June 25th. Royal Bank Of Canada lifted their price target on shares of Xylem from $157.00 to $159.00 and gave the company an “outperform” rating in a research report on Thursday, July 16th. JPMorgan Chase & Co. decreased their target price on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Finally, UBS Group boosted their price objective on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $153.15.

Xylem Trading Up 2.4%

Shares of XYL opened at $119.66 on Friday. The firm has a market capitalization of $28.44 billion, a P/E ratio of 29.77, a PEG ratio of 1.66 and a beta of 1.03. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. The firm’s 50-day moving average is $114.04 and its two-hundred day moving average is $122.82. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.11 billion. During the same quarter in the prior year, the firm earned $1.03 EPS. Xylem’s quarterly revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, research analysts predict that Xylem Inc. will post 5.52 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.